ENGLISH EDITION
                
              The turnaround of Lavipharm and the goal to double sales by 2029
                              
                  "We are a turnaround story, but we have now shifted to a trajectory of steady growth," stated Tilemachos Lavidas. "Dividend after 18 years. New production capabilities at the Peania factory."